Aurinia Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: VCP. There are 3 published signal records.
Aurinia Pharmaceuticals last closed at $16.65 (+2.65%) on 2026-10-09. Signals today: VCP. Listed on Nasdaq. Trailing 12 months PER is 7.1×. Its overall grade ranks 53 of 736 stocks in Healthcare.
About this company
Aurinia Pharmaceuticals last closed at $16.65 (+2.65%) on 2026-10-09. Signals today: VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 53/736
Valuation grade F
Related stocks
- Bristol Myers SquibbCompetitor
루푸스 신염 등 자가면역질환 영역에서 치료제 포트폴리오 경쟁
- AstraZenecaCompetitor
면역질환·희귀질환 치료제 개발 경쟁사
- GSKCompetitor
자가면역·희귀질환 분야 글로벌 제약 경쟁사
About Aurinia Pharmaceuticals
- What technical signals does Aurinia Pharmaceuticals (AUPH) have?
- Aurinia Pharmaceuticals current technical signals: VCP.
- Is Aurinia Pharmaceuticals a cup-and-handle pattern?
- No. Aurinia Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Aurinia Pharmaceuticals?
- Market cap: $2.2B. Trailing 12 months PER: 7.1×. Latest quarter PBR: 3.62×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Aurinia Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.